BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corbeddu M, Diociaiuti A, Vinci MR, Santoro A, Camisa V, Zaffina S, El Hachem M. Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series. J Eur Acad Dermatol Venereol 2021;35:e483-5. [PMID: 33834563 DOI: 10.1111/jdv.17268] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Han TY, Shim DH, Lee YJ, Lee YB, Koo HYR, Shin MK, Kim TE, Jang YH, Bang JS, Kook HD, Ahn J, Jung HJ, Na CH. Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study. Ann Dermatol 2023;35:38-45. [PMID: 36750457 DOI: 10.5021/ad.22.118] [Reference Citation Analysis]
2 Sharma R. Study of covid-19 vaccine-related cutaneous adverse events following immunization and establishing a causal association. J Eur Acad Dermatol Venereol 2023. [PMID: 36662656 DOI: 10.1111/jdv.18891] [Reference Citation Analysis]
3 Cabanillas B. Dupilumab for Atopic Dermatitis-From Clinical Trials to Molecular and Cellular Mechanisms. Dermatitis 2023;34:21-8. [PMID: 36705657 DOI: 10.1089/DERM.0000000000000905] [Reference Citation Analysis]
4 Oguz Topal I, Tokmak A, Kurmuş GI, Kalkan G, Demirseren DD, Tosun M, Emre S, Özkök Akbulut T, Kaya Özden H, Koska MC, Külcü Çakmak S, Kutlu Ö, Mutlu E, Gür Aksoy G, Topaloğlu Demir F, Karadağ AS. Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey. J Cosmet Dermatol 2022. [PMID: 36575896 DOI: 10.1111/jocd.15570] [Reference Citation Analysis]
5 Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. CCID 2022;Volume 15:2369-2382. [DOI: 10.2147/ccid.s388245] [Reference Citation Analysis]
6 Adams L, Nakafero G, Grainge MJ, Card T, Mallen CD, Van-tam JSN, Williams HC, Abhishek A. Is vaccination against COVID-19 associated with psoriasis or eczema flare? Self-controlled case series analysis using data from the Clinical Practice Research Datalink (Aurum). British Journal of Dermatology 2022. [DOI: 10.1093/bjd/ljac061] [Reference Citation Analysis]
7 Singh R, Freeman EE. Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin. Curr Derm Rep. [DOI: 10.1007/s13671-022-00370-9] [Reference Citation Analysis]
8 Taha Gul Shaikh, Summaiyya Waseem, Syed Hassan Ahmed, Nashwa Abdul Qadir, Vincenzo Piccolo. SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far? Dermatol Pract Concept 2022;12:e2022170. [PMID: 36534559 DOI: 10.5826/dpc.1204a170] [Reference Citation Analysis]
9 Gaspari V, Viviani F, Baraldi C, Neri I, Orioni G, Pileri A. Adverse events after anti-COVID-19 vaccine administration: a six-month experience. Ital J Dermatol Venereol 2022;157. [DOI: 10.23736/s2784-8671.22.07215-2] [Reference Citation Analysis]
10 . COVID-19 vaccine-Pfizer-BioNTech. Reactions Weekly 2022;1911:148-148. [DOI: 10.1007/s40278-022-17445-6] [Reference Citation Analysis]
11 Hung S, Preclaro IAC, Chung W, Wang C. Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies. Biomedicines 2022;10:1260. [DOI: 10.3390/biomedicines10061260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kroumpouzos G, Paroikaki ME, Yumeen S, Bhargava S, Mylonakis E. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review. Microorganisms 2022;10:624. [DOI: 10.3390/microorganisms10030624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Alamri A, Alghamdi Y, Alamri SJ, Althaqafi MK, Alqurashi W, Bader BA, Mohanna AT, Almahdi B. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine. Cureus 2022. [DOI: 10.7759/cureus.22414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 A. Rashid MR, Syed Mohamad SN, Suria A, Shahra R. Vesicular Rash Following Immunisation With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine: Vaccine Related or Coincidence? Cureus 2022. [DOI: 10.7759/cureus.22133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, Conforti C. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol 2022. [PMID: 35141881 DOI: 10.1111/ijd.16063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
16 Babazadeh A, Miladi R, Barary M, Shirvani M, Ebrahimpour S, Aryanian Z, Mohseni Afshar Z. COVID‐19 vaccine‐related new‐onset lichen planus. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Sil A, Jakhar D, Das A, Jagadeesan S, Aradhya SS. Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India. Indian J Dermatol 2022;67:115-20. [PMID: 36092222 DOI: 10.4103/ijd.ijd_893_21] [Reference Citation Analysis]
18 Ben Rejeb S, Beltaifa D, Dhaoui A, Derbel F, Bellil K. SARS-CoV-2 vaccine induced Sweet syndrome : a case report. Tunis Med 2021;99:1188-91. [PMID: 35288926] [Reference Citation Analysis]
19 Gronbeck C, Grant-Kels JM. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them! Clin Dermatol 2021;39:674-87. [PMID: 34809772 DOI: 10.1016/j.clindermatol.2021.05.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
20 Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines. J Clin Med 2021;10:5344. [PMID: 34830627 DOI: 10.3390/jcm10225344] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
21 Balogun M, Millette D, Yip V, Chan SA, Lee P, Gamal N, Hashim N, Phillips D, Walsh M, Trehan P, Hanna-Bashara L, Abdullah A, Wernham A, Tso S. Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review. Clin Exp Dermatol 2021. [PMID: 34748655 DOI: 10.1111/ced.15003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Bostan E, Zaid F, Akdogan N, Gokoz O. Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis. J Cosmet Dermatol 2021. [PMID: 34705320 DOI: 10.1111/jocd.14568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Niebel D, Wilhelmi J, De Vos L, Ziob J, Jaschke K, Bieber T, Wenzel J, Braegelmann C. Annular plaques mimicking Rowell's syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon? J Dermatol 2022;49:151-6. [PMID: 34693548 DOI: 10.1111/1346-8138.16210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, Barras M, Stücker M, Kasakovski D. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2021. [PMID: 34661927 DOI: 10.1111/jdv.17744] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 26.5] [Reference Citation Analysis]
25 Alhumaid S, Al Mutair A, Al Alawi Z, Rabaan AA, Tirupathi R, Alomari MA, Alshakhes AS, Alshawi AM, Ahmed GY, Almusabeh HM, Alghareeb TT, Alghuwainem AA, Alsulaiman ZA, Alabdulmuhsin MA, AlBuwaidi EA, Dukhi AKB, Mufti HN, Al-Qahtani M, Dhama K, Al-Tawfiq JA, Al-Omari A. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis. Allergy Asthma Clin Immunol 2021;17:109. [PMID: 34656181 DOI: 10.1186/s13223-021-00613-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
26 Darrigade AS, Théophile H, Sanchez-Pena P, Milpied B, Colbert M, Pedeboscq S, Pistone T, Jullié ML, Seneschal J. Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine. Allergy 2021;76:3194-6. [PMID: 34143448 DOI: 10.1111/all.14981] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
27 Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines. Dermatopathology (Basel) 2021;8:463-76. [PMID: 34698094 DOI: 10.3390/dermatopathology8040049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
28 Vaccaro M, Bertino L, Squeri R, Genovese C, Isola S, Spatari G, Spina E, Cutroneo P. Early atypical injection‐site reactions to COVID‐19 vaccine: a case series. J Eur Acad Dermatol Venereol 2022;36. [DOI: 10.1111/jdv.17683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
29 Zhang LW, Wang WJ, Li CH, Chen T. Erythema multiforme after SARS-CoV-2 vaccine. J Eur Acad Dermatol Venereol 2022;36:e32-3. [PMID: 34547118 DOI: 10.1111/jdv.17689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Sandhu S, Bhatnagar A, Kumar H, Dixit PK, Paliwal G, Suhag DK, Patil C, Mitra D. Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant). Dermatol Ther 2021;:e15141. [PMID: 34546608 DOI: 10.1111/dth.15141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
31 Iwata H, Kamiya K, Kado S, Nakaya T, Kawata H, Komine M, Ohtsuki M. Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination. J Dermatol 2021. [PMID: 34535924 DOI: 10.1111/1346-8138.16167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr 2021;112:828-36. [PMID: 34483343 DOI: 10.1016/j.adengl.2021.07.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Tihy M, Menzinger S, André R, Laffitte E, Toutous-Trellu L, Kaya G. Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines. J Eur Acad Dermatol Venereol 2021;35:2456-61. [PMID: 34459036 DOI: 10.1111/jdv.17633] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
34 Niebel D, Novak N, Wilhelmi J, Ziob J, Wilsmann-Theis D, Bieber T, Wenzel J, Braegelmann C. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Vaccines (Basel) 2021;9:944. [PMID: 34579181 DOI: 10.3390/vaccines9090944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
35 Chopra S, Kim Y, Flamm A. Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology. JAAD Case Rep 2021;16:24-5. [PMID: 34414254 DOI: 10.1016/j.jdcr.2021.07.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Annabi E, Dupin N, Sohier P, Garel B, Franck N, Aractingi S, Guégan S, Oulès B. Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature. J Eur Acad Dermatol Venereol 2021. [PMID: 34363637 DOI: 10.1111/jdv.17578] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
37 Novak N, Tordesillas L, Cabanillas B. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int Rev Immunol 2021;:1-10. [PMID: 34251972 DOI: 10.1080/08830185.2021.1939696] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
38 Leasure AC, Cowper SE, McNiff J, Cohen JM. Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34236729 DOI: 10.1111/jdv.17494] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
39 Cazzato G, Romita P, Foti C, Cimmino A, Colagrande A, Arezzo F, Sablone S, Barile A, Lettini T, Resta L, Ingravallo G. Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives. Vaccines (Basel) 2021;9:760. [PMID: 34358176 DOI: 10.3390/vaccines9070760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
40 Merhy R, Sarkis AS, Kaikati J, El Khoury L, Ghosn S, Stephan F. New-onset cutaneous lichen planus triggered by COVID-19 vaccination. J Eur Acad Dermatol Venereol 2021. [PMID: 34236718 DOI: 10.1111/jdv.17504] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
41 Ayatollahi A, Hosseini H, Firooz R, Firooz A. COVID-19 vaccines: What dermatologists should know? Dermatol Ther 2021;:e15056. [PMID: 34232548 DOI: 10.1111/dth.15056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
42 Edriss M, Farshchian M, Daveluy S. Localized cutaneous reaction to an mRNA COVID-19 vaccine. J Cosmet Dermatol 2021;20:2380-1. [PMID: 34129749 DOI: 10.1111/jocd.14288] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
43 Mintoff D, Pisani D, Betts A, Scerri L. SARS-CoV-2 mRNA vaccine-associated fixed drug eruption. J Eur Acad Dermatol Venereol 2021;35:e560-3. [PMID: 34036651 DOI: 10.1111/jdv.17390] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
44 Niebel D, Ralser-Isselstein V, Jaschke K, Braegelmann C, Bieber T, Wenzel J. Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine. Dermatol Ther 2021;34:e15017. [PMID: 34075664 DOI: 10.1111/dth.15017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
45 Afacan E, Öğüt B, Üstün P, Şentürk E, Yazıcı O, Adışen E. Radiation recall dermatitis triggered by inactivated COVID-19 vaccine. Clin Exp Dermatol 2021. [PMID: 34080223 DOI: 10.1111/ced.14786] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
46 Mazzatenta C, Piccolo V, Pace G, Romano I, Argenziano G, Bassi A. Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? J Eur Acad Dermatol Venereol 2021;35:e543-5. [PMID: 34048614 DOI: 10.1111/jdv.17340] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
47 Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr 2021:S0001-7310(21)00203-9. [PMID: 34052201 DOI: 10.1016/j.ad.2021.05.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 N Sheehan K, Zhao D. Pulmonary embolism after COVID-19 vaccination. J Case Rep Images Med 2021;7:1. [DOI: 10.5348/100064z09ks2021cs] [Reference Citation Analysis]